Plain-English translation of NCT07346079 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing Purified Cortrophin® Gel, a medication given as a single injection, to help relieve the pain and swelling of an acute gout flare. Researchers want to find out which dose works best — a lower dose or a higher dose — and how safe this treatment is for people who cannot take other common gout medications.
Many people with gout cannot take the standard treatments like NSAIDs (ibuprofen-type drugs) or colchicine because they don't work well for them, cause side effects, or aren't safe with their other medical conditions. This trial is testing whether this medication could offer a new option for people stuck without relief during a painful gout attack.
You likely qualify if…
You likely don't qualify if…
You will visit the research center on Day 0 to receive a single injection of the medication under your skin or into a muscle. You'll then be checked by phone or in-person at 24 hours, 48 hours, 72 hours, and again at 7 days to see how well the injection worked and to watch for any side effects. The entire study lasts about one week, and you'll report your pain levels and any symptoms during follow-up visits.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States